A Study on Lasunathabitham (Tonsillitis)

Gomathi, S (2013) A Study on Lasunathabitham (Tonsillitis). Masters thesis, Government Siddha Medical College, Palayamkottai.


Download (4MB) | Preview


AIM AND OBJECTIVES: AIM: To evaluate the clinical efficacy of Lasunathabitha chooranam and Adhondai kudineer in Lasunathabitham (Tonsillitis). OBJECTIVES: 1. To evaluate biochemical and pharmacological activities of the drug. 2. To know the degree of correlation of etiology, classification, signs and symptoms of Lasunathabitham with that of Tonsillitis of modern medicine. 3. To analyse the incidence of this disease among the children of age group 5 – 12 years. 4. To prevent the complications of Tonsillitis 5. To have an idea about the incidence of the disease with age, sex, socio economic status, family history and seasonal variations. 6. To know how the disease altered the normal conditions of uyir thathukkal, udal thathukkal, envagai thervu, neerkuri, neikuri etc. MATERIALS AND METHODS: Lasunathabitham (Tonsillitis) is one of the commonest infectious paediatric illness. The Clinical trial on Lasunathabitham was carried out in Out Patient and In Patient ward, Dept of Kuzhanthai Maruthuvam, Govt Siddha Medical College and Hospital, Palayamkottai. 50 cases were selected and treated with Lasunathabitha Chooranam and Adhondai Kudineer. Among 50 cases,30 cases were treated in OPD and 20 cases were treated in IPD. AIM: a) Primary Aim: To evaluate the clinical efficacy of LASUNATHABITHA CHOORANAM and ADHONDAI KUDINEER in LASUNATHABITHAM. b) Secondary Aim: To estimate the biochemical and pharmacological activities of the LASUNATHABITHA CHOORANAM and ADHONDAI KUDINEER. INCLUSION CRITERIA: • Age : 5-12 yrs. • Sex : both male and female children. • Sore throat. • Dysphagia due to tonsillar enlargement. • Fever. • Inflamed erythematous tonsils. • Cervical lymph adenitis due to tonsillitis. • Cough. • Nasal congestion. • Willing to give blood specimen for laboratory investigation when required. EXCLUSION CRITERIA: • Recent history of scarlet fever. • Rheumatic fever due to tonsillitis. • Peri tonsillar abscess. • Tonsil that needs surgical management. • Any other systemic illness along with tonsillitis. WITHDRAWAL CRITERIA : • Intolerance to the drug and development of adverse reactions during the drug trial. • Poor prognosis. • Patient turned unwilling to continue in the course of clinical trial. • Drugs response is not obtained within 8 days. • If any complications rise during drug trial. SUMMARY: The aim of the study is to evaluate the clinical efficacy of the trial drug “Lasunathabitha chooranam and Adhondai kudineer” in Lasunathabitham Sufficient literatures with reference to Lasunathabitham was not found in Siddha system. Hence from the available text, signs, symptoms and characteristic features were collected and the medicines was chosen for the study. 20 cases were selected and treated in IPD and 30 cases treated in OPD, Department of Kuzhanthai maruthuvam, Govt Siddha medical college, Palayamkottai for the clinical study. By both Siddha and modern methodology, the clinical diagnosis of Lasunathabitham was done. Higher incidence of Lasunathabitham was noticed between the age group of 7 – 10 years. Mainly school going children were affected by this disease. In treatment all the patients were given internally Lasunathabitha chooranam and Adhondai kudineer an average of 8 to 15 days as per the literature. The treatment was successful in reducing the signs and symptoms of the patients. The trial drug Lasunathabitha chooranam has sensitive anti microbial activity against streptococci and moderate sensitive against klebsiella. The trial drug Adhondai kudineer has sensitive anti microbial activity against streptococci, staphylococci, klebsiella and moderate sensitive against E.coli. Biochemical analysis revealed the trial medicine Lasunathabitha chooranam contains starch, ferrous iron, unsaturated compound. Adhondai kudineer contains calcium, sulphate starch, ferrous iron, tannic acid, unsaturated compound, amino acid. Pharmacological action of the Lasunathabitha chooranam had • Significant Anti pyretic action. • Moderate acute anti inflammatory action. • Moderate analgesic action. Adhondai kudineer had • Significant anti pyretic action. • Significant analgesic action. • Moderate acute anti inflammatory action. Improvement was observed from the second day of treatment. All the patients showed very good response. No adverse effect was produced during the drug trial period. The action of drug and progress in patients were encouraging and promising to pursue the medicine as standard one for Lasunathabitham in future. CONCLUSION: 1. The trial drug had profound effect in reducing symptoms like fever, swelling of the tonsils, dysphagia. 2. The trial medicines are safe to the patients. 3. The trial medicines are in simple form of preparation. 4. The trial medicines are cost effective. 5. No adverse effects were produced during the drug trial So it can be concluded that among the various infections rooting up in this seasonal change, Lasunathabitha chooranam and Adhondai kudineer proves to be excellent in combating the tonsillitis among children to produce healthy quality of life.

Item Type: Thesis (Masters)
Uncontrolled Keywords: Lasunathabitham ; Tonsillitis ; Lasunathabitha chooranam ; Adhondai kudineer.
Subjects: AYUSH > Kuzhanthai Maruthuvam
Depositing User: Kambaraman B
Date Deposited: 24 Apr 2018 10:09
Last Modified: 29 Dec 2018 15:58
URI: http://repository-tnmgrmu.ac.in/id/eprint/7271

Actions (login required)

View Item View Item